Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin

Clinical trial NCT01285609 · COMPLETED

Trial details

NCT number: NCT01285609
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer - Non Small Cell Squamous

Start date: 2011-01-16
Primary completion: 2015-06-09
Enrollment: 1289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.